ABERFORTH SMALLER COMPANIES TRUST PLC (ASL) — Research Note

Executive summary

Aberforth Smaller Companies Trust (ASCoT) is a closed-end UK investment trust that invests in small UK quoted companies (constituents of the Deutsche Numis Smaller Companies XIC index) under a strict value-investment philosophy, with 35 years of history under Aberforth Partners LLP. NAV total return has compounded at 11.7% p.a. since 1990, comfortably ahead of the benchmark's 9.7%, though the trust under-performed the DNSCI (XIC) by 472bps in 2025 and lagged the benchmark over the three-year continuation-vote period. The single most important point for valuation today is that the shares trade at an ~13% discount to a NAV of 1,745.26p (31 Dec 2025), and the portfolio's underlying companies are on EV/EBITA of just 7.2x for 2026 — so the discount itself is double-counted cheap exposure to UK smaller-companies value.

Fair value estimate

Methodology: Discount-to-NAV, anchored to the audited 31 Dec 2025 NAV of 1,745.26p, with a sensitivity for a moderate NAV roll-forward through 2026 (~3-5%) and a discount range of 5-12% reflecting peer norms for small-cap value investment trusts.
Key assumptions: NAV holds or modestly grows; gearing remains ~5%; discount can plausibly narrow given consistent buyback authority deployment (£60m in 2025 at 11.2% avg discount) and ongoing M&A realisations within the portfolio.
Fair value range per share: 1,580p – 1,720p (implied market cap range £1,250m – £1,360m on 79.1m shares in issue at 3 March 2026).
Mid-point: ~1,650p → implied market cap ~£1,305m.
Versus latest disclosed market cap of £1,198.6m: absolute upside ~9% to mid, range -1% to +13%.

Sector context

ICB classification confirmed: Financials / Financial Services (closed-end investment company / unit trust). This is a fund, not an operating company.
Quality/leverage profile is above typical sector peers: simple capital structure, no derivatives, modest 5% structural gearing, clean reporting under FRS 102 & AIC SORP, strong revenue reserves (99.1p per share post-2025 distribution).
Listed peers: Aberforth Geared Value & Income Trust (same manager), BlackRock Smaller Companies Trust (BRSC), Henderson Smaller Companies (HSL), Invesco Perpetual UK Smaller Companies (IPU).

Investment thesis

Deep triple-discount to historic norms. Portfolio historical PE of 10.5x vs 35-year average 12.0x, against UK large-cap 17.6x and global equities 18.1x; forward EV/EBITA on the portfolio is 7.2x for 2026 vs takeover multiples of 14.7x averaged over the last four years on completed bids in the universe 2026-01-29 Final Results.
Discount-to-NAV plus active buyback adds mechanical return. Shares trade ~13% below NAV with the Board running aggressive buybacks (4.08m shares cancelled in 2025 for £60m at 11.2% avg discount; £107m total returned to shareholders via dividends + buybacks in respect of 2025) 2026-01-29 Final Results.
Resilient income engine. Investment income grew 7% in 2025 to fund a 7.3% rise in the ordinary dividend plus a 12.0p special, with revenue reserves now 99.1p — almost two years' ordinary dividend cover allowing real dividend growth even through downturns 2026-01-29 Final Results.

Key risks

Cyclical exposure to UK small caps. Portfolio is value-tilted, with ~53% domestic revenue exposure and high weight in economically sensitive sectors; UK fiscal worries, gilt-yield gyrations and tariff overhang weighed on 2025 returns (-429bps portfolio attribution) 2026-01-29 Final Results.
Persistent style headwind from AI mania. Manager explicitly notes "great confidence... in the giant technology companies as they spend their billions on AI development" is the dominant flow story — value/small-cap UK is structurally out of favour, and this can persist for years (the trust lagged the benchmark over the three-year continuation-vote period to end-2025) 2026-01-29 Final Results.
Wide discount may not narrow. Despite consistent buybacks since 2008 (£226m deployed, only £33m of cumulative value added), the discount has remained 10-12% — there is no structural mechanism forcing convergence to NAV 2026-01-29 Final Results.

Operating leverage

This is a closed-end fund, not an operating company, so "operating leverage" in the conventional sense does not apply. The cost base is dominated by the management fee (0.75% on assets up to £1bn, 0.65% above), which scales linearly with NAV, plus modest other expenses. Total cost ratio ran at ~82bps of NAV in 2025 (mgmt fee £9.8m + other £1.0m + finance £4.5m vs avg NAV ~£1.4bn). There is no operational gearing to revenue surprises — the trust's returns are driven by portfolio gains and dividends received. The 5% structural gearing (£75m facility) provides modest financial gearing that amplifies NAV moves by ~5%. If you wanted operating-leverage exposure, you would have to look through to the underlying holdings, where many investee companies are themselves cyclical industrials and retailers with meaningful operating leverage to UK GDP recovery — but that is two layers removed from the buyer's portfolio.

Value-trap signals

None identified. NAV has compounded reliably over 35 years; the discount is wider than ideal but is not symptomatic of structural decline. The 2025 underperformance vs benchmark is a 1-year style issue, not a fundamental problem. Manager continues to add to personal holdings.

Earnings vs. expectations

As an investment trust, "earnings" are NAV total return vs the DNSCI (XIC) benchmark. Track record across the filing period: 2021 NAV TR +32.5% vs benchmark +21.9% (beat), 2022 -10.4% vs -17.9% (beat), 2023 +8.2% vs +10.1% (miss), 2024 +12.1% vs +9.5% (beat), 2025 +7.9% vs +12.7% (miss). Dividend ambition of CPI-plus growth has been consistently met or exceeded. Pattern: more relative beats than misses across cycles, but the 2025 miss combined with the 2023 underperformance meant the three-year continuation-vote period was a net miss (+31.0% vs +35.9%). Income/dividend delivery has consistently exceeded internal forecasts in the 2024 and 2025 reports.

Conviction

Conviction: 4 (high) that the shares are mildly undervalued (range straddles fair).

Anchors: NAV is audited, observable and Level-1-priced (£1,457.9m of listed equities); the discount is mechanical and the methodology is unambiguous; 35 years of consistent reporting.
Caveats: Discount could remain wide for years (no catalyst control), and the underlying NAV is itself subject to UK small-cap market risk, so the "fair value" is a moving target.

For the investor profile in question, this is fundamentally a poor strategic fit: ASCoT holds small UK value-style cyclicals, with essentially no AI-receiver exposure, near-zero operating leverage at the trust level, and limited long-tail upside to AI-spending cycles. The manager is explicit that the trust's appeal is precisely as the contrarian alternative to AI-mania — and the user's mandate is the opposite of contrarian-to-AI.